The analysis of the TCGA WGS/WES data revealed pan-cancer genetic alteration changes in CILP2, with most changes being mutations, and skin cutaneous melanoma having the most genetic variation, mainly in the form of mutations. This evidence concerns the gene CILP2 and cutaneous melanoma.